Scholars say constitutionally shaky infectious disease regulations must yield to better prevention programs.
Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.
Federal health agencies should work together to address public health problems.
Experts say federal agencies must clarify rules permitting payment to research subjects.
Scholar argues that agencies should collect evidence on surgical procedures to help implement best practices.
Scholar argues that FDA should reform its regulation of algorithm-based medicine.
Scholar praises a California law that widely eliminates antibiotics use in the livestock industry.
New study shows regulators have overlooked insurers in tackling the opioid epidemic.